Genetic Epidemiology of Telomere Maintenance and Cancer Etiology

端粒维持的遗传流行病学和癌症病因学

基本信息

项目摘要

Telomeres consist of long TTAGGG nucleotide repeats and associated proteins at the ends of chromosomes that are essential for the maintenance of chromosomal integrity. In order to preserve the chromosome end, the telomerase reverse transcriptase (TERT), its RNA component (TERC) and an ordered protein complex, termed shelterin, consisting of six proteins (gene names: TERF1, TERF2, TINF2, TERF2IP, ACD and POT1) protect the telomere from end-to-end fusion. Telomeric repeats are lost with each cell division, in part due to incomplete replication of the 3" end of the chromosome. Telomeric attrition eventually results in critically short telomeres prompting cellular senescence or cellular crisis, including apoptosis, genomic instability or a reduction in cellular lifespan. 1) Dyskeratosis congenita (DC) study: DC is an inherited bone marrow failure syndrome (IBMFS) and cancer predisposition disorder characterized by abnormalities in telomere biology and caused by germ-line mutations in one of several genes in the telomere pathways. We recently showed that telomere length, as measured by flow cytometry-FISH was both sensitive and specific for differentiation DC from other IBMFS. Identifying novel genes which might account for the 60% of DC patients who currently do not have detectable mutations in DKC1, TERC or TERT is one of the major goals of this study. Our recently completed a linkage study which has identified TINF2 as mutated in several families with DC. This study also focuses on careful clinical phenotyping. A comprehensive study of dysmorphology in DC is also underway. These studies will provide more specific data on genotype-phenotype interactions and aid in diagnosis of DC. 2) Telomere length in target tissues: These are a set of small, methodological studies that seek to clarify intra-individual variability in telomere length with the ultimate goal being improved understanding of comparability when different cell types and methods of telomere length determination are employed. Epidemiologic studies typically use DNA isolated from either blood or buccal cells, yet direct comparisons of telomere length in blood and buccal cell DNA have not been published. This study will evaluate intra- and inter- individual variation in telomere length in blood, buccal cell and fibroblast DNA in subjects enrolled in the inherited bone marrow failure syndromes study. It will also study the telomere length differences between buccal cell and blood DNA in healthy controls from an ovarian cancer study. 3) Telomere length as a risk factor for prostate cancer: Telomeres, telomere shortening and telomerase activity have emerged as important factors in prostate carcinogenesis. The earliest phase of human prostate carcinogenesis may proceed as a consequence of chromosomal instability mediated by shortened, dysfunctional telomeres. This is part of a case-control study of prostate cancer from the PLCO cohort. Telomere length was determined on 1200 controls and 700 cases of advanced prostate cancer Strong associations between telomere length and prostate cancer risk were not identified. However, longer telomeres were associated with a healthier lifestyle. 4) Novel genetic determinants of telomere length: The same subjects described in 3 were also part of a genome-wide association study (CGEMS, Cancer Genetic Markers of Susceptibility). In collaboration with Drs. Immaculata DeVivo and David Hunter (Harvard School of Public Health), we will add 1200 healthy controls from the Nurse"s Health Study who were part of the CGEMS breast cancer whole-genome scan. We are evaluating the relationship between genetic variants measured on the same platform in the CGEMS GWAS and telomere length (both measured in the same laboratory) among healthy controls: 1200 men and 1200 women. Lastly, interactions between genotypes affecting telomere length will be assessed in the prostate cancer cases and controls. . 5) Population genetics of telomere genes: We have previously shown that nucleotide diversity is low in genes important in telomere biology. This study will follow-up on those finding by evaluating genetic variation in more than 30 telomere biology genes in 1000 individuals from around the world. Insights into population history and identification of SNPs for genotyping in case-control studies will be possible..
端粒由长Ttaggg核苷酸重复序列和相关蛋白组成,在染色体的末端,对于维持染色体完整性至关重要。为了保留染色体末端,端粒酶逆转录酶(TERT),其RNA成分(TERC)和有序的蛋白质复合物,称为庇护素,称为庇护素,由六种蛋白质(基因名称:TERF1,TERF1,TERF2,TINF2,TINF2,TINF2,TERF2IP,ACD和POT1)保护远距离触发。每种细胞分裂都会丢失端粒重复,部分原因是染色体的3“末端的复制不完整。端粒损耗最终导致近距离端粒促使细胞衰老或细胞危机促使端粒造成较短(IBMF)和癌症易感障碍,其特征是端粒生物学异常,并由端粒途径中的几个基因中的一种生殖线突变引起,我们最近表明,通过流式细胞仪较高的态度,端粒长度既易于识别ibmf,又是鉴定出差异的人。 DKC1,TERC或TERT是我们最近完成的链接研究的主要目标。是一组小型的方法论研究,旨在阐明端粒长度的内部变异性,而最终目标是对端粒长度确定的不同细胞类型和方法的理解,而不是使用血液或脉络电细胞的比较,则使用了tebormere dna。在遗传的骨髓衰竭综合征中,血液,颊细胞和成纤维细胞DNA的端粒长度的变化还将研究卵巢癌的远期远期因素和远离型号的远期因素:远期的远期因素:远距离癌症。前列腺癌的最早,前列腺癌的最早,可能是由于较短的,功能障碍的端粒介导的染色体不稳定性。但是,较长的端粒与健康的生活方式相关。 CGEM乳腺癌全基因组扫描。我们正在评估健康对照中的CGEMS GWAS和端粒长度(均在同一实验室中测量的)在同一平台上测量的遗传变异之间的关系:1200名男性和1200名女性。最后,将在前列腺癌病例和对照组中评估影响端粒长度的基因型之间的相互作用。 。 5)端粒基因的种群遗传学:我们先前已经表明,核苷酸的多样性在端粒生物学中重要的基因较低。这项研究将通过评估来自世界上1000多个端粒生物学基因的遗传变异来进行对那些发现的跟进。可以在病例对照研究中对人群史和SNP进行基因分型的识别。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The evidence for prostate cancer risk loci at 8q24 grows stronger.
8q24 处前列腺癌风险位点的证据越来越充分。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon A. Savage其他文献

Living with rare genetic disease during the COVID-19 pandemic: A qualitative study of adolescents and young adults with Li-Fraumeni Syndrome
COVID-19 大流行期间患有罕见遗传病:对患有 Li-Fraumeni 综合征的青少年和年轻人的定性研究
  • DOI:
    10.1016/j.rare.2024.100034
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Allison Werner;Payal P. Khincha;Ashley S. Thompson;C. Rising;Alix G Sleight;Catherine Wilsnack;Patrick Boyd;Alexandra E. Feldman;R. F. Shepherd;Sharon A. Savage
  • 通讯作者:
    Sharon A. Savage
Donor Telomere Length Predicts Recipient Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Bone Marrow Failure Syndromes
  • DOI:
    10.1016/j.bbmt.2013.12.020
  • 发表时间:
    2014-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Shahinaz Gadalla;Tao Wang;Michael Haagenson;Stephen R. Spellman;Stephanie J. Lee;Kirsten M. Williams;Jason Y. Wong;Immaculata De Vivo;Sharon A. Savage
  • 通讯作者:
    Sharon A. Savage
Telomere Shortest Length Assay (TeSLA) Defines the Distribution and Accumulation of the Shortest Telomeres in Dyskeratosis Congenita
  • DOI:
    10.1182/blood-2022-168940
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Hannah A. Raj;Tsung-Po Lai;Marena R. Niewisch;Youjin Wang;Stephen R. Spellman;Abraham Aviv;Shahinaz M. Gadalla;Sharon A. Savage
  • 通讯作者:
    Sharon A. Savage
Relationship between plasma 25-hydroxyvitamin D and leucocyte telomere length by sex and race in a US study‡
美国研究中按性别和种族划分的血浆 25-羟基维生素 D 与白细胞端粒长度之间的关系‡
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Jason J Liu;E. K. Cahoon;M. Linet;Mark P. Little;C. Dagnall;Herbert Higson;Sharon A. Savage;D. Freedman
  • 通讯作者:
    D. Freedman
Chronic Inflammation Drives p53 Mutant Clonal Hematopoiesis Via Activating the NLRP1 Inflammasome
  • DOI:
    10.1182/blood-2022-169754
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Sergio of Barajas;Sasidhar Vemula;Sisi Chen;Hongxia Chen;Wenjie Cai;Shiyu Xiao;Stephanie Halene;Omar Abdel-Wahab;Linsey Mayo;Sharon A. Savage;Yan Liu
  • 通讯作者:
    Yan Liu

Sharon A. Savage的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon A. Savage', 18)}}的其他基金

Intervention Trials in Persons at Increased Genetic Risk of Cancer
针对癌症遗传风险增加人群的干预试验
  • 批准号:
    9549603
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Family Studies
家庭研究
  • 批准号:
    10007394
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
家族性和遗传性癌症综合征的临床遗传学研究
  • 批准号:
    10702919
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Family Studies
家庭研究
  • 批准号:
    10702899
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
端粒维持的遗传流行病学和癌症病因学
  • 批准号:
    8349586
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Epidemiology and Genetics of Susceptibility to COVID-19 Infection
COVID-19 感染易感性的流行病学和遗传学
  • 批准号:
    10702965
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Intervention Trials in Persons at Increased Genetic Risk of Cancer
针对癌症遗传风险增加人群的干预试验
  • 批准号:
    10007416
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
端粒维持的遗传流行病学和癌症病因学
  • 批准号:
    10007433
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Epidemiology and Genetics of Susceptibility to COVID-19 Infection
COVID-19 感染易感性的流行病学和遗传学
  • 批准号:
    10263793
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
家族性和遗传性癌症综合征的临床遗传学研究
  • 批准号:
    10263743
  • 财政年份:
  • 资助金额:
    $ 2.31万
  • 项目类别:

相似国自然基金

VNN1通过内质网非折叠蛋白应激介导单核巨噬细胞凋亡影响创伤患者脓毒症发生的机制研究
  • 批准号:
    82372549
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
  • 批准号:
    32372397
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
MLCK1介导细胞凋亡和自噬影响炎症性肠病进展
  • 批准号:
    82370568
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
EHMT1通过CBX4/MLKL轴调控心肌细胞坏死性凋亡影响心肌缺血再灌注损伤的机制研究
  • 批准号:
    82370288
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
应激颗粒自噬对低氧诱导猪卵泡颗粒细胞凋亡的影响及机制研究
  • 批准号:
    32302741
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

PRC1-dependent H2A Monoubiquitination During Human Corticogenesis
人类皮质生成过程中 PRC1 依赖性 H2A 单泛素化
  • 批准号:
    10604561
  • 财政年份:
    2023
  • 资助金额:
    $ 2.31万
  • 项目类别:
Oral Dysplasias to Carcinomas: Multi-omics Study of Progression
口腔发育不良到癌症:进展的多组学研究
  • 批准号:
    10770832
  • 财政年份:
    2023
  • 资助金额:
    $ 2.31万
  • 项目类别:
Sex chromosome gene regulatory networks and COPD
性染色体基因调控网络与慢性阻塞性肺病
  • 批准号:
    10570379
  • 财政年份:
    2023
  • 资助金额:
    $ 2.31万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 2.31万
  • 项目类别:
ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis.
坏死性小肠结肠炎和新生儿败血症发病机制中的 ROCK、紧密连接和早产。
  • 批准号:
    10659615
  • 财政年份:
    2023
  • 资助金额:
    $ 2.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了